These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8905919)

  • 1. Intermolecular interactions of antimicrobial fluoroquinolones with purified rat liver CYP1A2 studied by proton nuclear magnetic resonance spectroscopy.
    Mizuki Y; Yamamoto K; Yamaguchi T; Fujii T; Miyazaki H; Ohmori H
    Xenobiotica; 1996 Oct; 26(10):1057-66. PubMed ID: 8905919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variations of phenacetin metabolism in rats in vivo and in vitro.
    Starek A
    Pol J Pharmacol Pharm; 1992; 44(6):663-70. PubMed ID: 1305962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dimethyl sulfoxide on in vitro cytochrome P4501A2 mediated phenacetin O-deethylation in human liver microsomes.
    Nirogi R; Kandikere V; Bhyrapuneni G; Ponnamaneni RK; Palacharla Rc; Manoharan A
    Drug Metab Dispos; 2011 Nov; 39(11):2162-4. PubMed ID: 21825116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
    Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
    J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats.
    Zhu Q; Liao J; Xie L; Wang GJ; Liu XD
    Xenobiotica; 2009 Apr; 39(4):293-301. PubMed ID: 19350452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of dacarbazine by rat liver microsomes contribution of CYP1A enzymes to dacarbazine N-demethylation.
    Yamagata S; Ohmori S; Suzuki N; Yoshino M; Hino M; Ishii I; Kitada M
    Drug Metab Dispos; 1998 Apr; 26(4):379-82. PubMed ID: 9531528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.
    Wang X; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions.
    Karjalainen MJ; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):157-65. PubMed ID: 18816299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of theophylline and its inhibition by fluoroquinolones in rat hepatic microsomes.
    Davis JD; Aarons L; Houston JB
    Xenobiotica; 1995 Jun; 25(6):563-73. PubMed ID: 7483657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.
    Huang Q; Deshmukh RS; Ericksen SS; Tu Y; Szklarz GD
    Drug Metab Dispos; 2012 Dec; 40(12):2324-31. PubMed ID: 22949628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactions.
    Karjalainen MJ; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2006 Dec; 34(12):2091-6. PubMed ID: 16985100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction.
    Peterson TC; Peterson MR; Wornell PA; Blanchard MG; Gonzalez FJ
    Biochem Pharmacol; 2004 Jul; 68(2):395-402. PubMed ID: 15194011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Qingkailing injection on rat CYP1A2 and CYP2D6 activity].
    Liu Y; Wang J; Bao YY; Yu WJ; Zhu DL
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2044-7. PubMed ID: 18161301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline.
    Fukami T; Nakajima M; Sakai H; Katoh M; Yokoi T
    Drug Metab Dispos; 2007 Mar; 35(3):335-9. PubMed ID: 17178771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cytochromes P4501A induction and inhibition on the disposition of the cognition activator tacrine in rat hepatic preparations.
    Bezek S; Kukan M; Pool WF; Woolf TF
    Xenobiotica; 1996 Sep; 26(9):935-46. PubMed ID: 8893040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli.
    Kim DH; Kim KH; Isin EM; Guengerich FP; Chae HZ; Ahn T; Yun CH
    Protein Expr Purif; 2008 Feb; 57(2):188-200. PubMed ID: 18032064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenacetin O-deethylation is a useful tool for evaluation of hepatic functional reserve in rats with CCl(4)-induced chronic liver injury.
    Liu Z; Qu Z; Li X; Cai M; He P; Zhou M; Xiao J; Wang X
    J Surg Res; 2012 Jun; 175(2):e61-6. PubMed ID: 22341342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of microsomal and solubilized monooxygenases from rat and rabbit by proton magnetic relaxation.
    Maricić S; Benko B; Butschak G; Scheunig G; Jänig GR; Rein H; Ruckpaul K
    Acta Biol Med Ger; 1979; 38(2-3):217-33. PubMed ID: 229678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.